European Medicines Agency says AstraZeneca vaccine is 'safe and effective'

18 March 2021, 16:18 | Updated: 18 March 2021, 22:06

 The committee has found that the benefits outweigh any possible risks.
The committee has found that the benefits outweigh any possible risks. Picture: PA

By Harriet Whitehead

The European Medicines Agency has ruled that the Oxford AstraZeneca Covid-19 jab is a "safe and effective vaccine"

Emer Cooke, EMA executive director, says the committee has found that the benefits outweigh any possible risks.

The jab is not associated with an increase in the overall risk of thromboembolic events or blood clots, but based on available evidence, “we still cannot rule out definitively a link between these [blood clot] cases and the vaccine”.

Cooke adds that the AstraZeneca jab demonstrated at least a 60% efficacy in preventing coronavirus disease.

Cooke said: “During the investigation and review we began to see a small number of cases of rare and unusual but very serious clotting disorders and this then triggered a more focused review.

“Based on the available evidence and after days of in-depth analysis of lab results, clinical reports, autopsy reports and further information from the clinical trial we still cannot rule rule out definitively a link between these [blood clot] cases and the vaccine”.

Matt Hancock reveals reasons behind slower April Covid vaccine supply

As the EMA still could not rule this out it is therefore “recommending to raise awareness of these possible risks, making sure that they’re included in the product information”.

Decisions to suspend use of the vaccine by 13 EU states had sparked concerns.

Dr Sabine Strauss, chair of the EMA vaccine safety committee, said it has found “no evidence of a quality or a batch issue”.

She added the EMA found there is no higher overall risk of blood clots occurring after being vaccinated. In fact it likely reduces the likelihood.

READ MORE: No proven link between AstraZeneca jab and blood clots, says UK regulator

READ MORE: 1.7m doses need re-testing and supplies from India delayed, Matt Hancock confirms

This comes after the UK's medicines regulator today said the benefits of the AstraZeneca jab "far outweigh the risks" and that evidence suggests the jab does not cause blood clots.

The Medicines and Healthcare products Regulatory Agency (MHRA) said: "Following a rigorous scientific review of all the available data, the evidence does not suggest that blood clots in veins are caused by Covid-19 Vaccine AstraZeneca.

"Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. "People should still go and get their COVID-19 vaccine when asked to do so."

There have also been warnings that the number of people getting their first dose of the coronavirus vaccine will be “constrained” from the end of March due to a “significant reduction” in supply.

Housing Secretary says there is 'no cause for concern' over Covid jab

A letter to regional NHS bosses has said this reduction in the vaccine supply will be over a "four-week period" from the week beginning March 29.

Local health leaders have been told to focus efforts on the top nine priority groups. This means that those aged 49 years or younger should not be offered vaccination "unless they are eligible via a higher cohort".

These vaccine supply issues have reportedly been caused by a shipment of five million doses, produced by the Serum Institute of India, being delayed at the behest of the Indian government.

More Latest News

See more More Latest News

Yulia Navalnaya

Navalny widow accuses Putin of mocking Christianity for refusing to return body

Volodymyr Zelensky

Western leaders arrive in Kyiv as Ukraine marks invasion anniversary

Charles has shared a message of support for Ukraine

King Charles hails 'heroism' of Ukrainians as world leaders mark second anniversary of Russian invasion in Kyiv

Junior doctors have gone on strike again

Junior doctors walk out for five-day strike amid long-standing pay row, in latest round of NHS industrial action

Sarah Oliver was killed in the collision

Woman killed by driver who sped through red light while on her phone, as she is jailed for nine years

Spain Building Fire

10th body found in charred remnants of Valencia apartment building

Luiz Inacio Lula da Silva

Brazilian president accuses Israel of committing genocide in Gaza

Hamilton Palace is said to be abandoned

Crumbling Sussex mansion abandoned by millionaire developer 'is UK's biggest slum' and is 'magnet for drug abuse'

Grant Shapps has vowed that Britain will back Ukraine 'to the end'

'We will be there to the end': Shapps vows UK will back Ukraine until war is over, as Britain gives £245m military aid

Exclusive
LBC spoke to a mother and daughter from the war-torn city of Mariupol

Ukrainian refugees accuse Home Office of becoming ‘tired of Ukraine’ after altering resettlement schemes

Rishi Sunak has been urged to strip Liz Truss of the Conservative whip

Labour urges Rishi Sunak to strip former PM Liz Truss of Conservative whip after claim of 'deep state sabotage'

Ursula von der Leyen

EC chief von der Leyen arrives in Kyiv as Ukraine marks invasion anniversary

Mel B

'I went from Spice Girls tour to sharing a bed with my kids': Mel B had just £700 in the bank after leaving abusive ex

King Charles

King Charles chuckles at funny get-well card, one of 7,000 he was sent after cancer diagnosis

Palestine protesters outside Parliament

Palestine protest leader 'wanted Parliament to have to lock its doors', as fears grow for MP's safety

Election 2024 Trump

Trump says criminal indictments boosted his appeal to Black voters